Product NDC: | 0009-0626 |
Proprietary Name: | Depo-Provera |
Non Proprietary Name: | medroxyprogesterone acetate |
Active Ingredient(s): | 400 mg/mL & nbsp; medroxyprogesterone acetate |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-0626 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA012541 |
Marketing Category: | NDA |
Start Marketing Date: | 19601101 |
Package NDC: | 0009-0626-01 |
Package Description: | 2.5 mL in 1 VIAL (0009-0626-01) |
NDC Code | 0009-0626-01 |
Proprietary Name | Depo-Provera |
Package Description | 2.5 mL in 1 VIAL (0009-0626-01) |
Product NDC | 0009-0626 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | medroxyprogesterone acetate |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 19601101 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | MEDROXYPROGESTERONE ACETATE |
Strength Number | 400 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |